Placebo-controlled Evaluation of Ropivacaine Efficacy by Local Infiltrations

NACompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

February 28, 2014

Study Completion Date

April 30, 2015

Conditions
HepatectomyPainMetastasis
Interventions
DRUG

Ropivacaine

40 ml infiltration at the end of the hepatectomy and then continuous local infiltration of 8 ml per hour over the 4 days after the hepatectomy

DRUG

Physiological serum

40 ml infiltration at the end of the hepatectomy and then continuous local infiltration of 8 ml per hour over the 4 days after the hepatectomy

Trial Locations (1)

69373

Centre Léon Bérard, Lyon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

collaborator

Fondation Apicil

OTHER

lead

Centre Leon Berard

OTHER